share_log

美迪西(688202.SH)：现阶段在美国、欧洲、日韩地区已布局专业化的海外BD团队并不断加强团队建设

Medici (688202.SH): At this stage, specialized overseas BD teams have been deployed and team building has been continuously strengthened in the US, Europe, Japan, and South Korea

Gelonghui Finance ·  Feb 6 18:39

Gelonghui, Feb. 7 | Medici (688202.SH) recently said during a survey receiving institutional investors that at this stage, the company has deployed specialized overseas BD teams and continuously strengthened team building in the US, Europe, Japan and South Korea. In 2023, the company has arranged more than 30 exhibitions and conferences in the US, Europe, Japan, South Korea, etc., while increasing the frequency of regular expansion of research teams, gradually establishing a marketing and sales system adapted to overseas market competition, and continuing to strengthen customer follow-up development, especially for medium and large foreign pharmaceutical companies and high-quality biotechnology companies. At present, the company's R&D experimental base in Boston, USA has begun to be gradually put into use, which can better expand and serve local customers.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment